Dr. Idowu Oluwaseun Awosika, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 240 Wal Mart Way, Ste 5, Maysville, KY 41056 Phone: 606-759-0030 Fax: 606-759-0030 |
Eyecare Network Ltd Optometrist Medicare: Medicare Enrolled Practice Location: 1360 Medical Park Dr, Maysville, KY 41056 Phone: 606-759-5341 |
Ky Eye Institute Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1937 Old Main St Ste 1, Maysville, KY 41056 Phone: 606-759-7883 Fax: 606-759-0683 |
Eyecare Associates Optometrist Medicare: Medicare Enrolled Practice Location: 15 E 3rd St, Maysville, KY 41056 Phone: 606-564-3650 |
Keith T. Sherman, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 15 E 3rd St, Maysville, KY 41056 Phone: 606-564-3650 Fax: 606-564-3651 |
News Archive
University of Hawai'i Cancer Center researchers discovered a novel therapeutic target and treatment strategy for acute myeloid leukemia, a cancer of the blood and bone marrow that normally requires prompt and aggressive treatment.
Ovarian cancer is the fifth leading cause of death in American women, according to the American Cancer Society, and accounts for more deaths than any other cancer of the female reproductive system. And according to the National Cancer Institute, approximately 22,240 women will be diagnosed with the disease in 2018; 14,070 will die from it.
Sandra Roelofs, First Lady of Georgia; George Tsereteli, Georgia's Deputy Chairman of Parliament; and Irakli Giorgobiani, Georgia's Vice Minister of Labour, Health and Social Affairs, today signed the Vienna Declaration, the official declaration of the XVIII International AIDS conference in Vienna, Austria.
As the clock ticks toward the panel's Thanksgiving deadline, the question of raising taxes continues to be a sticking point. Republicans and Democrats appear to be trying to "horsetrade" revenue increases for entitlement program cuts. In the background, 33 Republican senators sent a letter to the committee insisting on "no net tax increase."
K-V Pharmaceutical Company today announced the completion and closing of the previously announced sale of assets of Nesher Pharmaceuticals, Inc., the Company's wholly-owned generic subsidiary, and the Company's generic business and assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals (USA) LLC.
› Verified 8 days ago